MedTrace Logo

Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.

NCT03752242 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2023-09-21

Study results available
· View outcomes & findings →

Summary

This is an exploratory Phase 2 trial of BMX-010 in patients with Acne Vulgaris which will be conducted in two parts.

Conditions

  • Acne Vulgaris

Interventions

DRUG

BMX-010 0.3%

Safety and efficacy of BMX-010 in topical treatment of acne.

Sponsors & Collaborators

  • BioMimetix JV, LLC

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-03
Primary Completion
2020-08-31
Completion
2020-08-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03752242 on ClinicalTrials.gov